Tweets
RA risk increased up to fivefold among patients with high CCP levels https://t.co/6VCMEsqx1p
Jeff Sparks @jeffsparks ( View Tweet )
7 years 7 months ago
National registry of lupus nephritis pts w/ ESRD (n=20,974) between 1995-2014 showed that mortality declined from 11.1 to 6.7/100PY; Mortality declined for whites (HR 0.68), blacks (0.67) and Hispanics (0.51) and declined for CVD and infx by 44% & 63% https://t.co/0zDQmLymes
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 7 months ago
Combined study of Danbio (Denmark) and ARTIS (Sweden) RA registries showed that in 8987 treatment courses of abatacept, rituximab or tocilizumab there was no difference in Serious infection rates - ranging from 4.7-8.1 SIE/100 Pt Yrs. https://t.co/JpYDeSPdpy
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 7 months ago
CDC report 5 Jan 2019: 7 million cases of influenza w/ an estimated 69,000 to 84,000 hospitalized for flu-related illness. H1N1 is the most common strain. Flu activity is widespread in 30 states https://t.co/kLsZjKDJen
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 7 months ago
Rheumatology Year in Review : New Drugs, irAEs, Enbrel in court, Opioids, new JAKs, Hot PsA Trial, new Lupus drugs, Medical Marijuana, Expen$ive Rheum drugs, Senolytics. https://t.co/9VpM4yRGfY
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 7 months ago
QD Video on RheumNow - an HLA-B27+ patient with Iritis, Enthesitis, Diarrhea. https://t.co/LusZttdAyw
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 7 months ago
QD Video from RheumNow - The RA patients with Thrombocytopenia https://t.co/GHn6b6Z3kb
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 7 months ago
RheumNow Podcast is up - discussing Gout FDA hearing, Gout Prevalence, ULT use, obesity, BMS-Celgene merger and more. Watch here https://t.co/J5xdqGYWAu Listen on iTunes or here> https://t.co/qHAO4E9cfX
Dr. John Cush @RheumNow ( View Tweet )
7 years 7 months ago
FDA AAC + DSRM advisory committee votes 19 yes, 2 no and 1 abstain on continued use of Uloric/febuxostat after reviewing CV risk in the CARES study. Await FDA decision, but Look for label changes.
Dr. John Cush @RheumNow ( View Tweet )
7 years 7 months ago
QD Video - lessons from the Clinic - How to evaluate the Takayasu's arteritis patient. https://t.co/tZcOOKlcVU
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 7 months ago
“The road to hell is paved with biologic plausibility”. - Dr. Steve Nissan
Dr. John Cush @RheumNow ( View Tweet )
7 years 7 months ago
Today - anuary 11, 2019: Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting to discuss Safety of Febuxostat v Allopurinol. No webcast. Here are briefing documents https://t.co/DXo3EX8u9y
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 7 months ago
Tuhina Neogi, MD, PhD, professor of medicine, has been named chief of the section of rheumatology, in the department of medicine at BU School of Medicine (BUSM) and Boston Medical Center (BMC). https://t.co/0HUj0ji40o
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 7 months ago
FDA has approved a single-injection hyaluronic acid (Durolane – Bioventus) and an ER formulation of the synthetic corticosteroid triamcinolone acetonide (Zilretta – Flexion) for intra-articular (IA) treatment of osteoarthritic knee pain. https://t.co/7rgsflNMVq
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 7 months ago
Cluster analysis of 157 SAPHO pts shows 3 distinct patterns or types - spinal type (44.6%; spinal, sacral); costal type (33.1%; ribs) and sternoclavicular type (22.3%) disease course was longer in SC type than costal or spinal types (P < 0.001). https://t.co/NI7AylAoZt
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 7 months ago
